Patients with a DCP ≥ 300 mAU/mL had a higher MELD score, more blood loss during LDLT, bigger tumor size by imaging study and explant pathology, more tumor nodules by imaging study and explant pathology, higher AFP, higher NLR, lower LMR, more positive microvascular invasion, and bilobar distribution by pathology. The gene discussed is AFP; the disease is neoplasm.